Джерело:
CNN.com
Дата публікації:
22/10/2019 23:39
Постійна адреса новини:
http://www.vsinovyny.com/6328686
22/10/2019 23:39 // CNN.com
In an unexpected reversal, pharmaceutical giant Biogen said it will pursue US Food and Drug Administration approval for aducanumab, an experimental treatment for early Alzheimer's disease, Biogen and its Japanese partner Eisai announced on Tuesday.
| « |
Наступна новина з архіву Japanese Hotel Chain Sorry That Hackers May Have Watched Guests Through Bedside Robots |
Попередня новина з архіву The White House's stone wall is starting to crumble |
» | |
|
|
||||